Acute Myelogenous Leukemia
Juvaris wins innovation research grant for acute myelogenous leukemia vaccine development
Published in Proteomics Weekly, October 23rd, 2006
Juvaris BioTherapeutics, Inc., announced award of a 1-year phase I small business innovation research (SBIR) grant from the U.S. National Cancer Institute (NCI) of the U.S. National Institutes of Health in collaboration with Dr. David Claxton at Pennsylvania State College of Medicine, Pennsylvania State University's medical school, for the development of a therapeutic vaccine approach for the treatment of acute myelogenous leukemia (AML).
Juvaris' vaccine technology will be tested in rodent tumor models to evaluate the impact on leukemia using an antigen-specific immunotherapeutic AML vaccine (JuvaVax). The SBIR grant application was supported by preclinical data...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
Source: Proteomics Weekly (2006-10-23)
More Articles from Proteomics Weekly
- Acute Myeloid Leukemia
Leukemogenic AML1-ETO-targeted proteins identified - Proteomics
Cardiac 20S proteasome function is modulated by associating partners - Proteomics
Cardiac sodium channel Nav 1.5 is regulated by multiprotein complex - Proteomics
Functional proteomics identifies targets for the MAP kinase pathway - Addiction Medicine
Nicotine-induced endothelial dysfunction is prevented by captopril - Aneurysms
Subarachnoid hemorrhage produces genetic changes in cerebral arteries - More from this issue of Proteomics Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
